Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Abstract The optimal management of very small vessel (reference diameter from 2.0 to 2.25 mm) in percutaneous coronary interventions (PCIs) is controversial. We aimed to compare the efficacy and safety of drug-coated balloons (DCBs) and drug-eluting stents (DESs) for de-novo very small vessel interv...

Full description

Bibliographic Details
Main Authors:	Cheng-Hsuan Tsai, Chih-Fan Yeh, Shih-Wei Meng, Chi-Sheng Hung, Mao-Shin Lin, Ching-Chang Huang, Chun-Kai Chen, Kuo-Ping Huang, Ying-Hsien Chen, Hsien-Li Kao
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-14047-7

Similar Items

Network meta-analysis of balloon angioplasty, nondrug metal stent, drug-eluting balloon, and drug-eluting stent for treatment of infrapopliteal artery occlusive disease
by: Yaowen Xiao, et al.
Published: (2016-09-01)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
by: Masaki Hirose, et al.
Published: (2023-01-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
by: Jonathan Hanna, et al.
Published: (2023-04-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Role of drug-coated balloon in the management of very late stent thrombosis
by: José Valencia, et al.
Published: (2023-05-01)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
by: Yi-Xing Yang, et al.
Published: (2023-01-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
by: Yong Zhu, et al.
Published: (2021-12-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
by: Yi-Xing Yang, et al.
Published: (2023-09-01)

Cost-effectiveness of Drug-eluting Stents in Patients With Stable Coronary Artery Disease
by: Chi-Sheng Hung, et al.
Published: (2011-02-01)

Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison
by: Nathan Marzlin, et al.
Published: (2022-01-01)

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
by: Hyungdon Kook, et al.
Published: (2020-02-01)

Scoring balloon versus drug-eluting balloon in coronary intervention for very small coronary vessels
by: Yasser Gaber Metwally, et al.
Published: (2021-01-01)

Drug-eluting balloons : dip-coated biodegradable films for sustained drug delivery
by: Nur Hazwani Abu Samah.
Published: (2010)

Drug-Coated Balloon vs. Drug-Eluting Stent in Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis
by: Zhen Fang, et al.
Published: (2023-07-01)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
by: Ae-Young Her, et al.
Published: (2023-05-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Drug-Coated Balloon Treatment of Very Late Stent Thrombosis Due to Complicated Neoatherosclerosis
by: Fernando Alfonso, et al.
Published: (2016-06-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
by: Yusuke Tsukada, et al.
Published: (2013-12-01)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
by: Mohd Shah, Azarisman Shah, et al.
Published: (2011)

Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis.
by: Kyohei Yamaji, et al.
Published: (2014-01-01)

Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study
by: Tharusha D. Gunawardena, et al.
Published: (2023-02-01)

Computational Pressure-Fluid Dynamics Applied to Index of Microcirculatory Resistance, Predicting the Prognosis of Drug-Coated Balloons Compared With Drug-Eluting Stents in STEMI Patients
by: Yang Duan, et al.
Published: (2022-05-01)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
by: Wonsuk Choi, et al.
Published: (2019-07-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

Safety and Feasibility of Drug-eluting Stent Implantation at Vertebral Artery Origin: The First Case Series in Asians
by: Yen-Hung Lin, et al.
Published: (2008-03-01)

Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
by: Zhi-Ming Jiang, et al.
Published: (2022-01-01)

A Case Summary of the Application of a Drug-Eluting Stent Combined with a Drug-Coated Balloon in Left Main Coronary Artery Disease
by: Rong-Xue Xiao, et al.
Published: (2022-04-01)

Debate. Drug-coated balloons for de novo coronary artery lesions. Still not enough evidence, and the new drug-eluting stents are still better
by: Manel Sabaté
Published: (2023-02-01)

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
by: Lulu Liu, et al.
Published: (2018-03-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Optimization of Drug Delivery by Drug-Eluting Stents.
by: Franz Bozsak, et al.
Published: (2015-01-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
by: Yen-Wen Liu, et al.
Published: (2021-09-01)

Drug-coated balloon therapy is more effective in treating late drug-eluting stent in-stent restenosis than the early occurring one—a systematic review and meta-analysis
by: Péter Kulyassa, et al.
Published: (2023-06-01)

Usefulness of Drug Eluting Stent in Percutaneous Coronary Intervention—A Single Center Experience in Taiwan
by: Juey-Jen Hwang, et al.
Published: (2007-08-01)

Short-term outcomes of drug-coated balloon versus drug-eluting stent for de novo saphenous vein graft lesions in coronary heart disease
by: Li Lin, et al.
Published: (2023-03-01)

Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
by: Satoshi Suzuki, et al.
Published: (2020-01-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)